96 related articles for article (PubMed ID: 17933750)
1. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
[TBL] [Abstract][Full Text] [Related]
2. Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.
Karjula S; Morin-Papunen L; Auvinen J; Ruokonen A; Puukka K; Franks S; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
J Clin Endocrinol Metab; 2017 Jun; 102(6):1861-1869. PubMed ID: 28323926
[TBL] [Abstract][Full Text] [Related]
3. Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
Hirschberg AL
J Clin Endocrinol Metab; 2024 Apr; 109(5):1202-1213. PubMed ID: 37886900
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention.
Osibogun O; Ogunmoroti O; Michos ED
Trends Cardiovasc Med; 2020 Oct; 30(7):399-404. PubMed ID: 31519403
[TBL] [Abstract][Full Text] [Related]
5. Maternal self-reported polycystic ovary syndrome with offspring and maternal cardiometabolic outcomes.
Polinski KJ; Robinson SL; Putnick DL; Sundaram R; Ghassabian A; Joseph P; Gomez-Lobo V; Bell EM; Yeung EH
Hum Reprod; 2024 Jan; 39(1):232-239. PubMed ID: 37935839
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries.
Melson E; Davitadze M; Malhotra K; ; Mousa A; Teede H; Boivin J; Thondan M; Tay CT; Kempegowda P
Front Endocrinol (Lausanne); 2023; 14():1217468. PubMed ID: 37614710
[TBL] [Abstract][Full Text] [Related]
7. Commentary: Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: A systematic review and meta-analysis.
Ke Y; Wu K; Liu S
Front Cardiovasc Med; 2022; 9():920144. PubMed ID: 36035914
[No Abstract] [Full Text] [Related]
8. Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Zhuang C; Luo X; Wang W; Sun R; Qi M; Yu J
Front Cardiovasc Med; 2022; 9():822079. PubMed ID: 35252398
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.
Alexandraki KI; Kandaraki EA; Poulia KA; Piperi C; Papadimitriou E; Papaioannou TG
touchREV Endocrinol; 2021 Apr; 17(1):37-53. PubMed ID: 35118445
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Properties of the Androgen-Induced PCOS Model in Rats: The Role of Oxidative Stress.
Joksimovic Jovic J; Sretenovic J; Jovic N; Rudic J; Zivkovic V; Srejovic I; Mihajlovic K; Draginic N; Andjic M; Milinkovic M; Milosavljevic Z; Jakovljevic V
Oxid Med Cell Longev; 2021; 2021():8862878. PubMed ID: 34512871
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Trial: Fish Oil and Metformin Effects on ApoB-Remnants and Triglycerides in Women With Polycystic Ovary Syndrome.
Vine D; Proctor E; Weaver O; Ghosh M; Maximova K; Proctor S
J Endocr Soc; 2021 Sep; 5(9):bvab114. PubMed ID: 34286169
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
[TBL] [Abstract][Full Text] [Related]
13. The role of androgen and its related signals in PCOS.
Ye W; Xie T; Song Y; Zhou L
J Cell Mol Med; 2021 Feb; 25(4):1825-1837. PubMed ID: 33369146
[TBL] [Abstract][Full Text] [Related]
14. ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome.
Vine DF; Beilin LJ; Burrows S; Huang RC; Hickey M; Hart R; Proctor SD; Mori TA
J Endocr Soc; 2020 Aug; 4(8):bvaa061. PubMed ID: 32803089
[TBL] [Abstract][Full Text] [Related]
15. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome.
Kempegowda P; Melson E; Manolopoulos KN; Arlt W; O'Reilly MW
Ther Adv Endocrinol Metab; 2020; 11():2042018820934319. PubMed ID: 32637065
[TBL] [Abstract][Full Text] [Related]
16. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles.
Jabbour R; Ott J; Eppel W; Frigo P
PLoS One; 2020; 15(4):e0232299. PubMed ID: 32330202
[TBL] [Abstract][Full Text] [Related]
17. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Reprod Biol Endocrinol; 2020 Mar; 18(1):23. PubMed ID: 32183820
[TBL] [Abstract][Full Text] [Related]
18. Sleeve Gastrectomy and Gastric Bypass Decrease the Carotid Intima-Media Thickness in Obese Men: Association with Weight Loss, Cardiovascular Risk Factors, and Circulating Testosterone.
Cobeta P; Osorio A; Cuadrado-Ayuso M; García-Moreno F; Pestaña D; Galindo J; Botella-Carretero JI
Obes Surg; 2020 Mar; 30(3):851-859. PubMed ID: 31925727
[TBL] [Abstract][Full Text] [Related]
19. Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome.
Heidari B; Lerman A; Lalia AZ; Lerman LO; Chang AY
Mayo Clin Proc; 2019 Dec; 94(12):2455-2466. PubMed ID: 31806099
[TBL] [Abstract][Full Text] [Related]
20. Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial.
Talari HR; Azad ZJ; Hamidian Y; Samimi M; Gilasi HR; Ebrahimi Afshar F; Ostadmohammadi V; Asemi Z
Int J Prev Med; 2019; 10():89. PubMed ID: 31360336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
